Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1037 | 1020 | 1047 | 1096 | 1358 | 2178 |
Fund Return | 3.71% | 1.96% | 4.69% | 3.1% | 6.32% | 8.1% |
Place in category | 539 | 606 | 503 | 365 | 178 | 22 |
% in Category | 82 | 95 | 85 | 69 | 39 | 7 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth | 4.27B | 5.68 | 6.11 | 9.92 | ||
Renaissance Global Growth Class F | 4.27B | 6.14 | 7.49 | 11.37 | ||
Renaissance International Equity | 1.84B | 3.26 | 1.77 | 6.65 | ||
Renaissance US Equity Income F | 1.42B | 6.77 | 7.73 | 10.34 | ||
Renaissance US Equity Income F Pr | 1.42B | 6.79 | 7.79 | 10.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC International Equity Sr F | 2.41B | 7.39 | 4.63 | 7.67 | ||
RBC International Equity Fund D USD | 2.41B | 7.29 | 4.34 | 7.39 | ||
Renaissance International Equity | 1.84B | 3.26 | 1.77 | 6.65 | ||
Manulife World Inv Cl Sr Adv | 1.59B | 5.21 | 0.57 | 5.56 | ||
Manulife World Inv Cl Sr F | 1.59B | 5.69 | 1.94 | 6.99 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.35 | 903.3 | -1.05% | |
ASML Holding | NL0010273215 | 3.64 | 864.70 | +1.37% | |
Keyence | JP3236200006 | 3.02 | 73,100.0 | -0.01% | |
Taiwan Semiconductor | US8740391003 | 2.93 | 153.59 | +1.26% | |
Experian | GB00B19NLV48 | 2.68 | 3,682.0 | -0.24% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review